Elucid turns routine coronary and carotid CT angiography into quantitative, histology-validated measurements of plaque type and composition, vessel anatomy and FFR physiology. Its FDA-cleared PlaqueIQ image-analysis software quantifies plaque biology and its FFR-CT product, under 510(k) review, adds physiology so clinicians can personalize treatment of atherosclerotic cardiovascular disease.